Oral administration of <i>Lacticaseibacillus rhamnosus</i> HM126 alleviates DNFB-induced atopic dermatitis in BALB/c mice by modulating immunity, gut microbiota, and metabolites.

Compared to the DNFB group, all dose groups showed a trend toward reduced scratching frequency during modeling, with the H-Larh group exhibiting the lowest frequency and significant differences ( p = 0.039 ) ( Figure 1D ).

also in 53,322 other papers